165 related articles for article (PubMed ID: 2616547)
1. Barrett's esophagus: a model premalignant lesion for adenocarcinoma.
Garewal HS; Sampliner R
Prev Med; 1989 Sep; 18(5):749-56. PubMed ID: 2616547
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive studies in Barrett's esophagus: a model premalignant lesion for esophageal adenocarcinoma.
Garewal HS; Sampliner RE; Fennerty MB
J Natl Cancer Inst Monogr; 1992; (13):51-4. PubMed ID: 1389696
[TBL] [Abstract][Full Text] [Related]
3. Barrett's esophagus and esophageal adenocarcinoma.
Reid BJ
Gastroenterol Clin North Am; 1991 Dec; 20(4):817-34. PubMed ID: 1787015
[TBL] [Abstract][Full Text] [Related]
4. [Barrett esophagus--a premalignant disorder requiring a program of endoscopic follow-up?].
Cuković-Cavka S
Med Arh; 2003; 57(1 Suppl 1):35-8. PubMed ID: 12827965
[TBL] [Abstract][Full Text] [Related]
5. Scanning electron microscopy of the human esophagus: application to Barrett's esophagus, a precancerous lesion.
Shields HM; Sawhney RA; Zwas F; Boch JA; Kim S; Goran D; Antonioli DA
Microsc Res Tech; 1995 Jun; 31(3):248-56. PubMed ID: 7670163
[TBL] [Abstract][Full Text] [Related]
6. Barrett's esophagus: model of neoplastic progression.
Ramel S
World J Surg; 2003 Sep; 27(9):1009-13. PubMed ID: 12917763
[TBL] [Abstract][Full Text] [Related]
7. Ornithine decarboxylase and polyamine levels in columnar upper gastrointestinal mucosae in patients with Barrett's esophagus.
Garewal HS; Gerner EW; Sampliner RE; Roe D
Cancer Res; 1988 Jun; 48(11):3288-91. PubMed ID: 3130189
[TBL] [Abstract][Full Text] [Related]
8. Progression to cancer in Barrett's esophagus is associated with genomic instability.
Rabinovitch PS; Reid BJ; Haggitt RC; Norwood TH; Rubin CE
Lab Invest; 1989 Jan; 60(1):65-71. PubMed ID: 2911184
[TBL] [Abstract][Full Text] [Related]
9. How Should We Report Endoscopic Results in Patient's with Barrett's Esophagus?
Gorrepati VS; Sharma P
Dig Dis Sci; 2018 Aug; 63(8):2115-2121. PubMed ID: 29675664
[TBL] [Abstract][Full Text] [Related]
10. [Carcinogenesis of Barrett's esophagus].
Endo T; Sugawara N; Shinomura Y
Nihon Rinsho; 2005 Aug; 63(8):1357-61. PubMed ID: 16101221
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence.
Walch AK; Zitzelsberger HF; Bruch J; Keller G; Angermeier D; Aubele MM; Mueller J; Stein H; Braselmann H; Siewert JR; Höfler H; Werner M
Am J Pathol; 2000 Feb; 156(2):555-66. PubMed ID: 10666385
[TBL] [Abstract][Full Text] [Related]
12. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
[TBL] [Abstract][Full Text] [Related]
13. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
14. Barrett's esophagus, dysplasia, and adenocarcinoma.
Haggitt RC
Hum Pathol; 1994 Oct; 25(10):982-93. PubMed ID: 7927321
[TBL] [Abstract][Full Text] [Related]
15. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
[TBL] [Abstract][Full Text] [Related]
16. Is Obesity Associated with Barrett's Esophagus and Esophageal Adenocarcinoma?
Lynch KL
Gastroenterol Clin North Am; 2016 Dec; 45(4):615-624. PubMed ID: 27837776
[TBL] [Abstract][Full Text] [Related]
17. From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.
Wang RH
World J Gastroenterol; 2015 May; 21(17):5210-9. PubMed ID: 25954094
[TBL] [Abstract][Full Text] [Related]
18. Barrett's oesophagus: microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence.
Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Weber JL; Russell SE
Genes Chromosomes Cancer; 1998 Jan; 21(1):49-60. PubMed ID: 9443041
[TBL] [Abstract][Full Text] [Related]
19. Cellular mechanisms of Barrett's esophagus development.
Barbera M; Fitzgerald RC
Surg Oncol Clin N Am; 2009 Jul; 18(3):393-410. PubMed ID: 19500732
[TBL] [Abstract][Full Text] [Related]
20. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
